Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
AIBD Regionals April NC
Session V: What’s New In 2022: Case-Based
What’s New In Biosimilars For IBD
Saturday, April 2, 2022
5:10 PM – 5:30 PM
Speaker(s)
Uni Wong, MD
University of Maryland School of Medicine
Baltimore, Maryland
This session is supported by an independent educational grant from Amgen, Inc.
Learning Objectives:
Evaluate the most recent clinical data associated with biosimilars for the management of IBD
Consider the approval process that ensures the efficacy and safety of biosimilars
Integrate biosimilars into clinical practice where appropriate for the treatment of IBD